Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk’s Magazine. As technology advances there is a growing array of MedTech solutions – wearables, ...

AstraZeneca (AZ) and Merck’s – known as MSD outside the US and Canada – Lynparza (olaparib) has been recommended by the National Institute for Health and Care Excellence (NICE) as part of a ...

New national surveillance data announced at the UK Health Security Agency (UKHSA) annual conference has demonstrated an increase in antibiotic resistant infections and associated deaths in England.

The US government has announced the ten drugs selected for the first round of pricing negotiations under President Biden’s Inflation Reduction Act (IRA). The IRA allows Medicare, the government health ...

The US Food and Drug Administration (FDA) has approved the over-the-counter (OTC), non-prescription use of Harm Reduction Therapeutics’s RiVive, a 3mg naloxone hydrochloride nasal spray, for the ...

The US health department has proposed three new models to help lower the cost of drugs, promote accessibility and improve quality of care for those enrolled in voluntary government health insurance ...

Researchers at the Institute of Cancer Research (ICR) in London have discovered new inhibitors that block the action of a protein involved in driving several cancer types. According to the team, with ...

The World Health Organization (WHO) has unveiled plans to establish a tuberculosis (TB) vaccine accelerator council to speed up the licensing and use of effective novel vaccines against the disease.

BioNTech has announced it will acquire UK AI start-up InstaDeep in a deal worth up to £562m, following the company’s initial equity investment as part of InstaDeep’s Series B financing round in ...

Gilead and EVOQ Therapeutics (EVOQ) have entered into a collaboration and licensing agreement aimed at advancing immunotherapies for the treatment of rheumatoid arthritis (RA) and lupus. Under the ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has received a total of £970,688 from the Department for Business, Energy and Industrial Strategy’s (BEIS) Regulators’ Pioneer Fund. The ...

Merck & Co – known as MSD outside the US and Canada – and Moderna have announced positive phase 2b trial results investigating the use of their personalised mRNA cancer vaccine, mRNA-4157/V940, in ...